Patent · US Active

Imidazolidine-2,4-dione derivatives

US9676752B2 · kind B2 · utility

0Cited by

2References

14Claims

0Family size

Assignee

IPSEN PHARMA S.A.S. · FR

Inventors

Serge Auvin · Mauchamps, FR
Christophe Lanco · Étampes, FR
Qi Chao · San Diego, US
Kaichun Gu · Shanghai, CN

Key dates

Filing date	Dec 31, 2013
Grant date	Jun 13, 2017
Priority date	—
Expiry date	Dec 31, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D233/74
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Imidazolidine-2,4-dione derivatives of formula (I):The compounds have anti-proliferative activity and are useful for treating pathological states and diseases linked to an abnormal cell proliferation such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.